Regulation of COPII Vesicle Coating — Obsoletion & Replacement

IN_PROGRESS OBSOLETION

Regulation of COPII Vesicle Coating — Obsoletion & Replacement

Overview

A GO obsoletion proposal will retire GO:0003400 regulation of COPII vesicle
coating
(BP) and merge its annotations into GO:0048208 COPII vesicle
coating
(BP). The rationale, captured in the upstream ontology ticket, is
that the proteins currently annotated to GO:0003400 act part_of the COPII
vesicle coating pathway (they are components of the coating machinery —
SAR1, SEC12, SEC23, SEC16, SED4, PEF1, PREB) rather than upstream regulators
of that pathway, so the "regulation of …" parent does not describe their
biology accurately. One UniProt entry on the upstream list (human MAPK15,
Q8TD08) is being disputed and is slated for removal rather than transfer.

The replacement term GO:0048208 is also being renamed at the same time:

(both labels were rebranded to clearer "coat assembly" wording in the
go-ontology PR opened in response to the obsoletion request).

This project tracks the impact on AI Gene Review and queues affected genes
for review, since none of the directly annotated genes are currently in this
repository.

Upstream tickets

Obsoletion plan (per upstream)

Obsoleted term ID Replacement
regulation of COPII vesicle coating GO:0003400 GO:0048208 COPII vesicle coat assembly (renamed from "COPII vesicle coating")

Term labels were verified in OLS on 2026-05-24. Both GO:0003400 and
GO:0048208 are still live in OLS at the time of this check (the obsoletion
will become visible after the next GO release ingests PR #32013).

Affected experimental annotations (from upstream spreadsheet)

11 EXP annotations across two groups (SGD 8, UniProt 3). Pulled from the
upstream Google Sheet on 2026-05-24:

# Group Gene Species ID PMID Evidence PANTHER Status
1 SGD SAR1 S. cerevisiae SGD:S000006139 PMID:14627716 IDA PTHR45684 move to GO:0048208
2 SGD SAR1 S. cerevisiae SGD:S000006139 PMID:15665868 IDA PTHR45684 move to GO:0048208
3 SGD SED4 S. cerevisiae SGD:S000000663 PMID:21291503 IDA PTHR23284 move to GO:0048208
4 SGD PEF1 S. cerevisiae SGD:S000003290 PMID:22792405 IDA PTHR46212 move to GO:0048208
5 SGD PEF1 S. cerevisiae SGD:S000003290 PMID:22792405 IMP PTHR46212 move to GO:0048208
6 SGD PEF1 S. cerevisiae SGD:S000003290 PMID:22792405 IPI (with SGD:S000002354) PTHR46212 move to GO:0048208
7 SGD SEC12 S. cerevisiae SGD:S000005309 PMID:8377826 IDA PTHR23284 move to GO:0048208
8 SGD SEC23 S. cerevisiae SGD:S000006385 PMID:8451644 IDA PTHR11141 move to GO:0048208
9 UniProt SEC16A H. sapiens UniProtKB:O15027 PMID:17005010 IMP PTHR13402 move to GO:0048208
10 UniProt MAPK15 H. sapiens UniProtKB:Q8TD08 PMID:24618899 IMP PTHR24055 DISPUTED — to be removed (ValWood, per upstream issue body)
11 UniProt PREB H. sapiens UniProtKB:Q9HCU5 PMID:32358066 IDA PTHR23284 move to GO:0048208

Mappings flagged for redirection

No InterPro2GO or UniProt-Keywords mappings to GO:0003400 were listed in the
upstream issue.

Impact on this repo

No genes directly annotated to GO:0003400 are currently reviewed here.
Searches under genes/ for SAR1, SED4, PEF1, SEC12, SEC23, SEC16A, MAPK15,
and PREB (and the UniProt accessions O15027, Q8TD08, Q9HCU5) returned no
matches on 2026-05-24. This means no existing reviews need refresh for
the obsoletion itself; the project is a queueing exercise that lines up
COPII machinery components for prospective review.

The repo currently has a related COPII track in
projects/ only via the parallel vesicle-targeting / vesicle-tethering
obsoletions (VESICLE_TARGETING_OBSOLETION.md,
SYNAPTIC_VESICLE_DOCKING_OBSOLETION.md,
ER_PM_TETHERING_OBSOLETION.md,
MITO_ER_TETHERING_OBSOLETION.md,
CILIARY_BASAL_BODY_DOCKING_OBSOLETION.md), and via the yeast ERV14 review
(tracked separately in #402
against #6406
for COPII cargo receptor activity). Adding canonical COPII coating
components (SAR1, SEC23, SEC16) here would substantially strengthen the
ER-to-Golgi early-secretory-pathway coverage.

Scope

Candidate genes for initial review

Verify each with just fetch-gene <organism> <gene> before starting. None
are currently in the repo.

Tier 1 — canonical COPII coat GTPase + scaffold

  1. SAR1A (human, UniProt Q9NR31) — small Ras-family GTPase that
    nucleates COPII coat assembly on the ER membrane after activation by
    SEC12 (the cognate GEF). The yeast SAR1 entry on the upstream list
    (SGD:S000006139, PMID:14627716 and PMID:15665868) reflects the same
    biology; reviewing the human SAR1A is the highest-value anchor here
    because SAR1A is well-studied, has clear core function (GTPase activity
    driving COPII coat assembly), and serves a similar didactic role to
    CEP290 in the parallel cilia-obsoletion project.
  2. SEC23A (human, UniProt Q15436) — inner-layer COPII coat subunit
    and SAR1 GAP. The yeast SEC23 entry (SGD:S000006385, PMID:8451644)
    captures the canonical biochemistry. SEC23A loss-of-function causes
    cranio-lenticulo-sutural dysplasia, so the gene is also clinically
    well-characterised — a good complement to SAR1A.

Tier 2 — coat-recruiting / scaffolding regulators with direct annotations

  1. SEC16A (human, UniProt O15027) — the human direct-annotation
    target on the upstream list (PMID:17005010, IMP). SEC16A organises
    transitional-ER exit sites and recruits the SAR1/SEC23/SEC24 complex.
    Confirming GO:0048208 as core function and reviewing the broader
    ER-exit-site machinery annotations would be useful.
  2. PREB / SEC12 (human, UniProt Q9HCU5) — the human direct-annotation
    target on the upstream list (PMID:32358066, IDA). PREB is the mammalian
    SEC12 ortholog, a guanine nucleotide exchange factor for SAR1. Pairs
    naturally with the SAR1A review.

Tier 3 — yeast-only entries (lower repo priority)

  1. Yeast SAR1, SEC12, SEC23, SED4, PEF1 (SGD) — the 8 SGD direct
    annotations cover the same biology as the human Tier 1/2 entries. A
    single human-anchored review per family is more efficient than separate
    yeast reviews, but the SED4 and PEF1 entries describe accessory
    regulators (SED4 = SEC12 paralog without measurable GEF activity in
    vitro; PEF1 = penta-EF-hand calcium-binding protein with a non-canonical
    regulatory role) that have no direct human equivalent in this repo yet,
    so a yeast PEF1 review would be worth adding once the canonical entries
    are in.

Special case — disputed annotation

  1. MAPK15 / ERK7 (human, UniProt Q8TD08) — the disputed
    PMID:24618899 IMP annotation. Worth a focused review only if there is
    independent interest in MAPK15; for the obsoletion-tracking purpose, the
    simpler action is to wait for the upstream removal and not start a
    ground-up MAPK15 review here.

Proposed approach

  1. Wait for the obsoletion to land before bulk-rewriting. The upstream
    ontology ticket #31945 is CLOSED and the corresponding PR (#32013) was
    opened on 2026-04-22; the obsoletion + rename will be visible once a
    GO release ingests it. Reviews can proceed on the underlying biology
    now using the live GO:0048208 term ID (action codes ACCEPT / MODIFY /
    REMOVE are independent of the obsoletion timing).
  2. Begin with SAR1A (human) as the anchor review. The COPII coat GTPase
    is the canonical example for the replacement term and has substantial
    biochemistry / cryo-EM literature for core_functions synthesis.
  3. Follow with SEC23A (human) to cover the inner coat layer and the
    SAR1-GAP relationship — gives a paired review that exercises the
    GTPase / GAP partnership in one of the field's textbook examples.
  4. Add SEC16A and PREB if the project expands beyond the GTPase /
    GAP pair, since they are the human entries actually on the upstream list.
  5. Defer the yeast-only entries (SAR1, SEC12, SEC23, SED4, PEF1) and
    the disputed MAPK15 unless interest develops; the human Tier 1/2 reviews
    cover the biology more efficiently for this repo's audience.
  6. Cross-reference with the ERV14 COPII cargo receptor project
    (#402,
    tracking go-annotation#6406)
    — that project covers the cargo-recognition side of COPII budding,
    which sits immediately downstream of the coat-assembly biology covered
    here.
  7. Flag the disputed MAPK15 annotation upstream if interest develops in
    reviewing it locally; otherwise the upstream removal stands on its own.

Priority

Medium-low. The biology is canonical and well-established, and no
existing reviews are blocked by the obsoletion (no SAR1 / SEC23 / SEC16 /
PREB reviews exist here yet). This is opportunistic — SAR1A and SEC23A in
particular are major unreviewed components of the early secretory pathway,
so the obsoletion is a reasonable trigger to start that coverage.

Status